Leap Therapeutics
LPTX
LPTX
63 hedge funds and large institutions have $168M invested in Leap Therapeutics in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.18% more ownership
Funds ownership: 3.62% → 4.8% (+1.2%)
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16M | |
| 2 | +$14.1M | |
| 3 | +$10M | |
| 4 |
TLP
Tri Locum Partners
New York
|
+$7.26M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$6.62M |
Top Sellers
| 1 | -$5.86M | |
| 2 | -$507K | |
| 3 | -$257K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$201K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$85K |